Anti-TNFRSF5/CD40 Anticody (Teneliximab)
Catalog No.
F1081
Anti-TNFRSF5/CD40 Anticody (Teneliximab)
Featured Products
Teneliximab (BMS-224819) is a chimeric monoclonal antibody that blocks the CD40-CD40L interaction. Teneliximab (BMS-224819) exerts partial agonist activity through CD40 and peripheral B cell depletion.
146.02 kDa
Dry ice
299423-37-3
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
chi220, BMS-224819
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P25942
Human
Unconjugated
Monoclonal
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
TNFRSF5 / CD40
Please avoid freeze-thaw cycles.